Poliovirus vaccine oral - Bilthoven BiologicalsAlternative Names: BBio Bivalent Oral Polio Vaccine - Bilthoven Biologicals; BBio bOPV - Bilthoven Biologicals
Latest Information Update: 01 Jun 2016
At a glance
- Originator Bilthoven Biologicals
- Developer Serum Institute of India
- Class Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Poliomyelitis
Most Recent Events
- 01 May 2016 Phase-III clinical trials in Poliomyelitis (In children, In infants, Prevention) in Bangladesh (PO) (NCT02766816)